Author:
Luo Shuying,Cui Weihong,Li Chan,Ling Feng,Fu Tao,Liu Qiyong,Ren Jiangping,Sun Jimin
Funder
National Basic Research Program of China
Medical Research Program of Zhejiang Province
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. World Health Organization: Dengue: guidelines for diagnosis, treatment, prevention and control.
http://www.who.int/csr/resources/publications/dengue_9789241547871/en
(2009). Accessed 15 Nov 2014.
2. Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, et al. The global distribution and burden of dengue. Nature. 2013;496:504–7.
3. Lau L, Green AM, Balmaseda A, Harris E. Antibody avidity following secondary dengue virus type 2 infection across a range of disease severity. J Clin Virol. 2015;69:63–7.
4. Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, et al. Cross-reacting antibodies enhance dengue virus infection in humans. Science. 2010;328:745–8.
5. de Alwis R, Williams KL, Schmid MA, Lai CY, Patel B, Smith SA, et al. Dengue viruses are enhanced by distinct populations of serotype cross-reactive antibodies in human immune sera. PLoS Pathog. 2014;10:e1004386.
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献